DBXX 📈 Xtrackers - FTSE 100 - Overview
Exchange: XETRA • Country: Germany • Currency: EUR • Type: Etf • ISIN: LU0292097234 • UK Large-Cap Equity
DBXX: Equities, UK, Dividend, Stocks, Shares, Income
‣ Company URL: http://www.dws.lu ‣ Domicile: Luxembourg ‣ Index Name: Morningstar UK All Cap TME NR GBP
Additional Sources for DBXX ETF
DBXX ETF Overview
| Market Cap in USD | 66m |
| Category | UK Large-Cap Equity |
| TER | 0.09% |
| IPO / Inception | 2007-06-05 |
DBXX ETF Ratings
| Growth 5y | 50.0% |
| Fundamental | - |
| Dividend | 39.2% |
| Rel. Strength Industry | -52.2 |
| Analysts | - |
| Fair Price Momentum | 9.35 EUR |
| Fair Price DCF | - |
DBXX Dividends
| Dividend Yield 12m | 4.43% |
| Yield on Cost 5y | 5.31% |
| Annual Growth 5y | -0.74% |
| Payout Consistency | 82.1% |
DBXX Growth Ratios
| Growth Correlation 3m | -3.1% |
| Growth Correlation 12m | 79.7% |
| Growth Correlation 5y | 91.6% |
| CAGR 5y | 3.64% |
| CAGR/Mean DD 5y | 0.52 |
| Sharpe Ratio 12m | 0.37 |
| Alpha | -10.47 |
| Beta | 0.64 |
| Volatility | 14.91% |
| Current Volume | 1.2k |
| Average Volume 20d | 4.1k |
What is the price of DBXX stocks?
As of January 03, 2025, the stock is trading at EUR 9.49 with a total of 1,168 shares traded.
Over the past week, the price has changed by -0.38%, over one month by -2.15%, over three months by -1.64% and over the past year by +8.60%.
As of January 03, 2025, the stock is trading at EUR 9.49 with a total of 1,168 shares traded.
Over the past week, the price has changed by -0.38%, over one month by -2.15%, over three months by -1.64% and over the past year by +8.60%.
Is Xtrackers - FTSE 100 a good stock to buy?
Partly, yes. Based on ValueRay Analyses, Xtrackers - FTSE 100 (XETRA:DBXX) is currently (January 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 50.04 and therefor an somewhat technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of DBXX as of January 2025 is 9.35. This means that DBXX is currently overvalued and has a potential downside of -1.48%.
Partly, yes. Based on ValueRay Analyses, Xtrackers - FTSE 100 (XETRA:DBXX) is currently (January 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 50.04 and therefor an somewhat technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of DBXX as of January 2025 is 9.35. This means that DBXX is currently overvalued and has a potential downside of -1.48%.
Is DBXX a buy, sell or hold?
Xtrackers - FTSE 100 has no consensus analysts rating.
Xtrackers - FTSE 100 has no consensus analysts rating.
What are the forecast for DBXX stock price target?
According to ValueRays Forecast Model, DBXX Xtrackers - FTSE 100 will be worth about 10.3 in January 2026. The stock is currently trading at 9.49. This means that the stock has a potential upside of +8.32%.
According to ValueRays Forecast Model, DBXX Xtrackers - FTSE 100 will be worth about 10.3 in January 2026. The stock is currently trading at 9.49. This means that the stock has a potential upside of +8.32%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 10.3 | 8.3% |